Trial intelligence / Profile preview

Sodium bicarbonate versus saline hydration for prevention of contrast-induced nephropathy after CT angiography

NL-OMON21374Active, not recruiting

Sponsor
Leiden University Medical Center
Start
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of sodium bicarbonate and sodium chloride in contrast-induced nephropathy (CIN) (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Incidence of contrast-induced nephropathy at 3 to 5 days and Persistent contrast-induced nephropathy or dialysis at 2 months. Started Jan 2010; status: active, not recruiting.

02

Drugs

sodium bicarbonatesodium chloride
03

Conditions

contrast-induced nephropathy (CIN)

Beyond the preview

Go deeper on NL-OMON21374.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON21374.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call